Global Sodium Iodide [131I] Oral Solution Market Growth (Status and Outlook) 2023-2029
The global Sodium Iodide [131I] Oral Solution market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Sodium Iodide [131I] Oral Solution is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Sodium Iodide [131I] Oral Solution is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Sodium Iodide [131I] Oral Solution is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Sodium Iodide [131I] Oral Solution players cover Jubilant Radiopharma, IBM Micromedex, ANSTO, International Isotopes Inc., China Isotope & Radiation Corporation and Yantai Dongcheng, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Sodium Iodide [131I] Oral Solution Industry Forecast” looks at past sales and reviews total world Sodium Iodide [131I] Oral Solution sales in 2022, providing a comprehensive analysis by region and market sector of projected Sodium Iodide [131I] Oral Solution sales for 2023 through 2029. With Sodium Iodide [131I] Oral Solution sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sodium Iodide [131I] Oral Solution industry.
This Insight Report provides a comprehensive analysis of the global Sodium Iodide [131I] Oral Solution landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sodium Iodide [131I] Oral Solution portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sodium Iodide [131I] Oral Solution market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sodium Iodide [131I] Oral Solution and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sodium Iodide [131I] Oral Solution.
This report presents a comprehensive overview, market shares, and growth opportunities of Sodium Iodide [131I] Oral Solution market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
250 mCi
500 mCi
1000 mCi
Segmentation by application
Hyperthyroidism
Thyroid
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Jubilant Radiopharma
IBM Micromedex
ANSTO
International Isotopes Inc.
China Isotope & Radiation Corporation
Yantai Dongcheng
Please note: The report will take approximately 2 business days to prepare and deliver.